Fisabio

What Fisabio does

Fisabio (full legal name: Fundació per al Foment de la Investigació Sanitària i Biomèdica de la Comunitat Valenciana, in Spanish: Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana) is a public non-profit foundation established in 2008 and headquartered in Valencia, Spain, operating under the Generalitat Valenciana's Conselleria de Sanitat. It functions as the centralized vehicle for healthcare and biomedical research promotion in the Valencian Community, coordinating 173 research groups, 939 research staff, 284 active projects, and 623 clinical trials across four health departments plus a dedicated Fisabio Public Health area. Its service portfolio includes technology licensing (29 patents), clinical trial management, public health surveillance (epidemiology, genomics, antimicrobial resistance monitoring), and a consolidated Research Portal. Technical infrastructure centers on a Massive Sequencing Service (NextSeq 500), a Bioinformatics Platform supporting the Research Portal, a Biosafety Level 3 laboratory, mass spectrometry, and an interoperability-managed Valencian Biobank Network. Operations are distributed across regional hospital sites in Valencia, Elche, Castellón, Alicante, Alzira, and Vila-real.

Revenue mechanics are non-commercial: Fisabio does not sell products to external customers. Funding flows from four streams — recurring institutional transfers from the Conselleria de Sanitat, FEDER co-financing (EU structural funds) for research infrastructure, PRTR NextGenEU recovery funds, and competitive national/international research grants (e.g., Instituto de Salud Carlos III, FECYT, IVACE+i). The foundation also generates modest technology-licensing income through its Innovation area. Leadership is constituted as a Patronato presided over by the regional Conseller de Sanitat, with María Luisa Caparrós Redondo serving as Directora Gerente (Managing Director).

Notable recent activity includes leadership of a European initiative on home care safety (2026), a joint decalogue with Universitat Jaume I on generative AI in care research (2026), and the EQUILAB wellbeing initiative (2026), alongside compliance with the Spanish Esquema Nacional de Seguridad and GDPR frameworks.

Name

Fisabio

Legal name

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (Fisabio)

Website

https://fisabio.san.gva.es

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

101–250 employees

Short description

Fisabio is a public non-profit foundation under the Generalitat Valenciana that coordinates biomedical and public health research across 173 research groups and four regional health departments, managing clinical trials, genomic surveillance, a biobank network, and a technology licensing portfolio for the Valencian Community.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Public Administration (92)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA), Investigator & Site Training / GCP Support (HLAGACAF)

Keywords

• Biomedical research
• Public health research
• Clinical trial management
• Genomic sequencing services
• Biobank network management

Headquarters

HQ city

Valencia

HQ country

Spain

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

1. Public Institutional Funding: Core funding from the Generalitat Valenciana's Consellería de Sanitat for healthcare and biomedical research promotion in the Valencian Community
2. European Regional Development Fund (FEDER): EU co-financing for research infrastructure, equipment, and innovation projects under the 2014-2020 operational program for Valencia
3. PRTR NextGenEU Funding: Recovery and Resilience funds for research and innovation projects
4. Competitive Research Grants: Project-based funding from national and international competitive calls for research projects

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Fisabio operates as a multi-service biomedical and public health research foundation for the Valencian Community, providing technology licensing, clinical trial management, public health research, genomic sequencing, and a consolidated research portal that serves the regional healthcare system. Its offerings are delivered through institutional collaboration rather than commercial sales channels.

Product overview

Fisabio is a public foundation for health and biomedical research in the Valencian Community, Spain. It operates as a multi-service research organization offering technology licensing, clinical trial management, public health research, and a consolidated research portal. The foundation manages 173 research groups, 939 research staff, and 284 current projects. Its technology portfolio includes innovations available for licensing, while its research portal provides information consolidation for biomedical research management across the regional health system.

Differentiator

Problem solved

Functional benefit

Products and services

• Technology Portfolio and Licensing

Quantifiable outcome

• 284 active research projects across 173 research groups
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core.

• Universitat Jaume IcoreStrategic or Co-development PartnerAcademic research partner contributing to collaborative programs including AI in healthcare research and general biomedical collaboration
• Universitat de ValènciacoreStrategic or Co-development PartnerUniversity partner represented on Fisabio's Board of Trustees (Patronato) through Carlos Hermenegildo Claudevilla
• Universidad Miguel Hernández d'ElxcoreStrategic or Co-development PartnerUniversity partner represented on Fisabio's Board of Trustees through Antonio Miguel Picó Alfonso
• Valencian Community Biobank NetworkcoreStrategic or Co-development PartnerNetwork of biobanks across the region with interoperability management system for biological sample sharing and research collaboration
• Laboratory Network for Antimicrobial Resistance SurveillancecoreStrategic or Co-development PartnerRegional network for monitoring antimicrobial resistance with shared sequencing and laboratory equipment

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• IRB Barcelona (Institute for Research in Biomedicine): Spanish biomedical research institute with strengths in computational biology, genomics, and structural biology; comparable to Fisabio's genomic and bioinformatics capabilities and its role as a regional research coordination entity.
• IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer): Barcelona-based biomedical research foundation linked to Hospital Clínic that similarly coordinates clinical research across a hospital network, manages active trials, and operates as a centralized vehicle for regional health research — directly comparable in mandate and operating model to Fisabio.
• VHIO (Vall d'Hebron Institut d'Oncologia): Oncology-focused research foundation embedded within the Vall d'Hebron University Hospital in Barcelona; comparable as a hospital-anchored clinical research foundation with substantial trial activity and translational research programs.
• ISGlobal (Barcelona Institute for Global Health): Public-health-focused research institute with genomics and epidemiology capabilities; comparable to Fisabio-Salut Pública on outbreak surveillance, antimicrobial resistance, and population health research.
• CIBER (Centro de Investigación Biomédica en Red): Spanish national consortium of biomedical research groups organized into thematic areas; comparable to Fisabio in coordinating distributed research groups and clinical trial activity across multiple hospital sites.
• CRG (Centre for Genomic Regulation): Barcelona-based genomics and computational biology research institute; directly comparable to Fisabio's sequencing service and bioinformatics platform capabilities.

Others

• EATRIS (European Infrastructure for Translational Medicine): European distributed research infrastructure providing translational medicine services; comparable as an ecosystem participant in cross-border biomedical research coordination rather than a direct competitor.

Regional players

• Institut Pasteur: French biomedical research foundation with comparable multi-site research model, public health mandate, and infrastructure for infectious disease and genomic research; relevant as a comparable European public research foundation model.

Broad incumbents

• ISCIII (Instituto de Salud Carlos III): Spain's national public health research institute and a major funder of biomedical research; directly comparable as a public-sector research funder and operator, and an existing institutional partner of Fisabio.
• CNIO (Centro Nacional de Investigaciones Oncológicas): Spain's national cancer research centre; broader in scope and national in mandate, but comparable as a publicly funded biomedical research entity conducting translational and clinical research in a hospital-network-adjacent model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/GVAfisabio
• Facebookfacebook.com/fundacionfisabio
• LinkedInlinkedin.com/company/fisabio

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fisabio